118 related articles for article (PubMed ID: 29927965)
1. Genetic profile and patient-reported outcomes in chronic obstructive pulmonary disease: A systematic review.
Melro H; Gomes J; Moura G; Marques A
PLoS One; 2018; 13(6):e0198920. PubMed ID: 29927965
[TBL] [Abstract][Full Text] [Related]
2. Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study.
Mandal J; Malla B; Steffensen R; Costa L; Egli A; Trendelenburg M; Blasi F; Kostikas K; Welte T; Torres A; Louis R; Boersma W; Milenkovic B; Aerts J; Rohde GG; Lacoma A; Rentsch K; Roth M; Tamm M; Stolz D
Respir Res; 2015 Dec; 16():150. PubMed ID: 26684757
[TBL] [Abstract][Full Text] [Related]
3. Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections.
Yang IA; Seeney SL; Wolter JM; Anders EM; McCormack JG; Tunnicliffe AM; Rabnott GC; Shaw JG; Dent AG; Kim ST; Zimmerman PV; Fong KM
Genes Immun; 2003 Jun; 4(4):269-74. PubMed ID: 12761563
[TBL] [Abstract][Full Text] [Related]
4. Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use?
Ekström M; Sundh J; Larsson K
Expert Rev Respir Med; 2016; 10(3):351-62. PubMed ID: 26808786
[TBL] [Abstract][Full Text] [Related]
5. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
7. Mannose-binding lectin gene polymorphism contributes to recurrence of infective exacerbation in patients with COPD.
Lin CL; Siu LK; Lin JC; Liu CY; Chian CF; Lee CN; Chang FY
Chest; 2011 Jan; 139(1):43-51. PubMed ID: 20688922
[TBL] [Abstract][Full Text] [Related]
8. Stage 1 development of a patient-reported experience measure (PREM) for chronic obstructive pulmonary disease (COPD).
Walker S; Andrew S; Hodson M; Roberts CM
NPJ Prim Care Respir Med; 2017 Jul; 27(1):47. PubMed ID: 28740181
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
[TBL] [Abstract][Full Text] [Related]
10. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
[TBL] [Abstract][Full Text] [Related]
11. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
12. Airway clearance techniques for chronic obstructive pulmonary disease.
Osadnik CR; McDonald CF; Jones AP; Holland AE
Cochrane Database Syst Rev; 2012 Mar; (3):CD008328. PubMed ID: 22419331
[TBL] [Abstract][Full Text] [Related]
13. Commonly Used Patient-Reported Outcomes Do Not Improve Prediction of COPD Exacerbations: A Multicenter 4½ Year Prospective Cohort Study.
Strassmann A; Frei A; Haile SR; Ter Riet G; Puhan MA
Chest; 2017 Dec; 152(6):1179-1187. PubMed ID: 28923760
[TBL] [Abstract][Full Text] [Related]
14. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
[TBL] [Abstract][Full Text] [Related]
15. Identifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methods.
Morrow JD; Qiu W; Chhabra D; Rennard SI; Belloni P; Belousov A; Pillai SG; Hersh CP
BMC Med Genomics; 2015 Jan; 8():1. PubMed ID: 25582225
[TBL] [Abstract][Full Text] [Related]
16. Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.
Ferguson GT; Karpel J; Bennett N; Clerisme-Beaty E; Grönke L; Voß F; Buhl R
NPJ Prim Care Respir Med; 2017 Feb; 27(1):7. PubMed ID: 28154373
[TBL] [Abstract][Full Text] [Related]
17. Association of group component genetic variations in COPD and COPD exacerbation in a Japanese population.
Ishii T; Motegi T; Kamio K; Gemma A; Kida K
Respirology; 2014 May; 19(4):590-5. PubMed ID: 24735339
[TBL] [Abstract][Full Text] [Related]
18. Tiotropium versus placebo for chronic obstructive pulmonary disease.
Karner C; Chong J; Poole P
Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
[TBL] [Abstract][Full Text] [Related]
19. Beclometasone for chronic obstructive pulmonary disease.
De Coster DA; Jones M; Thakrar N
Cochrane Database Syst Rev; 2013 Oct; (10):CD009769. PubMed ID: 24105424
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
